Comorbidities of geriatric psoriasis: A cross-sectional study with 75 patients

Alper Alyanak 1, *, Kıymet Handan Kelekci 1, Nurhan Döner Aktaş 1, Işıl Ezgi Urgancı Tatlı 2 and Büşra Emir 3

1 Department of Dermatology, Izmir Katip Çelebi University, Medical Faculty, Atatürk Research and Education Hospital, Izmir, Turkey.
2 Department of Dermatology, Kocaeli Körfez State Hospital, Kocaeli, Turkey.
3 Department of Biostatistics, Izmir Katip Çelebi University Medical Faculty, Izmir, Turkey.
 
Research Article
International Journal of Science and Research Archive, 2023, 09(02), 309–314.
Article DOI: 10.30574/ijsra.2023.9.2.0567
Publication history: 
Received on 08 June 2023; revised on 18 July 2023; accepted on 21 July 2023
 
Abstract: 
Objective: Our aim in this study was to determine comorbid diseases in the elderly with psoriasis.
Methods: This cross-sectional study was conducted on 75 psoriasis patients, aged 65-85 years, and 75 control patients without psoriasis. Psoriasis clinical features and comorbidities were recorded during the physical examination and taking anamnesis. Comorbidities were also searched from the hospital registration system. Comorbidities were compared between the groups.
Results: It was determined that metabolic syndrome-associated diseases and other diseases which were chronic bronchitis, pneumonia, hypothyroidism, and depression were statistically increased from the control group (p<0.05). Obesity was found to be high in both groups but was not statistically different between the groups (p>0.05).
Conclusion: Our findings show that metabolic syndrome-associated diseases were all increased and should be investigated in geriatric psoriasis patients. Larger sample size studies would better delineate the other comorbidities. Systemic therapy should be carefully evaluated because of systemic involvement in psoriasis and also side effects on major organ systems.
 
Keywords: 
Comorbidity; Geriatrics; Metabolic syndrome; Psoriasis
 
Full text article in PDF: